Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Domedicon Invest AB
AB
Active
Org 5567701296
General medical practice activities
· NACE 8621
Est. 2008
0 employees
Watchlist
Share
Sweden
/
Companies
/
General medical practice activities
/
Domedicon Invest AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
1M
2M
3M
3M
2M
2022
2M
2023
3M
2024
2M
2025
1M
2025
EBITDA
SEK millions
0M
1M
1M
2M
2M
1M
2022
1M
2023
1M
2024
2M
2025
0M
2025
Income statement
SEK thousands
Item
2022
2023
2024
2025
2025
Revenue
2 159
1 787
2 557
2 222
582
Staff expenses
−684
−679
−997
−261
−293
EBITDA
1 390
1 011
1 418
1 836
239
Depreciation & amort.
—
—
—
—
—
EBIT
1 390
1 011
1 418
1 836
239
Net financials
−1
1
13
9
−0
Profit before tax
1 041
801
1 124
1 378
377
Tax
−215
−168
−238
−289
−82
Net profit
826
633
886
1 089
295
Balance sheet
SEK thousands
Item
2022
2023
2024
2025
2025
Total assets
5 671
6 677
6 768
7 508
7 487
Equity
4 123
4 156
4 606
5 695
5 678
Long-term debt
—
—
—
—
—
Short-term debt
937
1 698
1 033
217
350
Total debt
937
1 698
1 033
217
350
Financial ratios
5-year trend
EBITDA margin
41.1%
This company
15.8%
Market median
+160% vs market
2022
2025
Equity ratio
75.8%
This company
38.2%
Market median
+98% vs market
2022
2025
Return on equity
5.2%
This company
18.4%
Market median
-72% vs market
2022
2025
Net profit margin
50.7%
This company
8.1%
Market median
+526% vs market
2022
2025
Asset turnover
0.08×
This company
1.12×
Market median
-93% vs market
2022
2025
Debt / equity
0.32×
This company
0.62×
Market median
+48% vs market
2022
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-07-01 – 2025-12-31
View
PDF
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
View
PDF
More on Domedicon Invest AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
Riskpilot